This Is MS Multiple Sclerosis Community: Knowledge & Support

In December, Accentia Bio changed the name of their Multiple Sclerosis therapy Revimmune (HiCy or High Dose Cytoxan) to Cyrevia.

As the company is working toward starting PH III trials this year, it is also registered the domain name www.cyrevia.com to reserve the name for Cyrevia.

In step with these announcments, Johns Hopkins has stated "We're in the planning stages of trying to have a larger multi-center clinical trial for HiCy, but this is likely 1-2 years away from being a reality"

I am interested in this treatment....seems like its very risky but has the best chance of halting the disease.